ID

14469

Description

ACVBP Followed by ASCT in Patients With BCL-2 Positive Diffuse Large B-Cell Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00169130

Lien

https://clinicaltrials.gov/show/NCT00169130

Mots-clés

Versions (1)
  1. 17/04/2016 17/04/2016 -
Téléchargé le

17 avril 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Lymphoma, Large-Cell, Diffuse NCT00169130

Anglais

Eligibility Lymphoma, Large-Cell, Diffuse NCT00169130

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
patient with diffuse large b-cell lymphoma according to the who classification (anti cd20 labeling)
Description

Diffuse large b-cell lymphoma

Type de données

boolean

Alias
UMLS CUI [1]
C0079744
aged 18 to 60 years
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
non previously treated
Description

Previous treatment

Type de données

boolean

Alias
UMLS CUI [1]
C0087111
with one and only one of the following adverse characteristics: ecog performance status 2 or more, or ann arbor stage iii or iv, or elevated ldh level
Description

ECOG performance status, ann arbor stage and ldh level

Type de données

boolean

Alias
UMLS CUI [1]
C1520224
UMLS CUI [2]
C0432516
UMLS CUI [3]
C0202113
negative hiv, hbv and hcv serologies (except vaccination)
Description

HIV, HBV, HVC Serologoy

Type de données

boolean

Alias
UMLS CUI [1]
C0019698
UMLS CUI [2]
C0853319
UMLS CUI [3]
C0201485
with a minimum life expectancy of 3 months
Description

Life expectancy

Type de données

boolean

Alias
UMLS CUI [1]
C0023671
having previously signed a written informed consent
Description

Informed consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
any history of treated or non-treated indolent lymphoma.
Description

Indolent lymphoma

Type de données

boolean

Alias
UMLS CUI [1]
C1334170
t-cell lymphoma.
Description

T-cell lymphoma

Type de données

boolean

Alias
UMLS CUI [1]
C0079772
central nervous system or meningeal involvement by lymphoma.
Description

CNS or meningeal lymphoma

Type de données

boolean

Alias
UMLS CUI [1]
C0280803
UMLS CUI [2]
C2213017
any contra-indication to any drug contained in the chemotherapy regimens.
Description

Contraindication to chemotherapy

Type de données

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0392920
poor renal function (creatinin level>150µmol/l), poor hepatic function (total bilirubin level>30mmol/l, transaminases>2.5 maximum normal level) unless these abnormalities are related to the lymphoma.
Description

Renal and hepatic functio

Type de données

boolean

Alias
UMLS CUI [1]
C0201976
UMLS CUI [2]
C0201913
UMLS CUI [3]
C0919834
serious active disease (according to the investigator’s decision).
Description

Comorbidity

Type de données

boolean

Alias
UMLS CUI [1]
C0009488
poor bone marrow reserve as defined by neutrophils <1.5g/l or platelets<100g/l, unless related to bone marrow infiltration.
Description

Bone marrow function

Type de données

boolean

Alias
UMLS CUI [1]
C0200633
UMLS CUI [2]
C0032181
any history of cancer during the last 5 years with the exception of non-melanoma skin tumors or stage 0 (in situ) cervical carcinoma.
Description

Further malignancies

Type de données

boolean

Alias
UMLS CUI [1,1]
C0006826
UMLS CUI [1,2]
C0332196
UMLS CUI [1,3]
C0007114
UMLS CUI [2,1]
C0006826
UMLS CUI [2,2]
C0332196
UMLS CUI [2,3]
C2216722
treatment with any investigational drug within 30 days before planned first cycle of chemotherapy and during the study.
Description

Experimental drug

Type de données

boolean

Alias
UMLS CUI [1]
C0304229
childbearing woman.
Description

Pregnancy

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
patients previously treated with an organ transplantation.
Description

Organ transplantation

Type de données

boolean

Alias
UMLS CUI [1]
C0029216
Retour au début de la page

Similar models

Eligibility Lymphoma, Large-Cell, Diffuse NCT00169130

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Diffuse large b-cell lymphoma
Item
patient with diffuse large b-cell lymphoma according to the who classification (anti cd20 labeling)
boolean
C0079744 (UMLS CUI [1])
Age
Item
aged 18 to 60 years
boolean
C0001779 (UMLS CUI [1])
Previous treatment
Item
non previously treated
boolean
C0087111 (UMLS CUI [1])
ECOG performance status, ann arbor stage and ldh level
Item
with one and only one of the following adverse characteristics: ecog performance status 2 or more, or ann arbor stage iii or iv, or elevated ldh level
boolean
C1520224 (UMLS CUI [1])
C0432516 (UMLS CUI [2])
C0202113 (UMLS CUI [3])
HIV, HBV, HVC Serologoy
Item
negative hiv, hbv and hcv serologies (except vaccination)
boolean
C0019698 (UMLS CUI [1])
C0853319 (UMLS CUI [2])
C0201485 (UMLS CUI [3])
Life expectancy
Item
with a minimum life expectancy of 3 months
boolean
C0023671 (UMLS CUI [1])
Informed consent
Item
having previously signed a written informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Indolent lymphoma
Item
any history of treated or non-treated indolent lymphoma.
boolean
C1334170 (UMLS CUI [1])
T-cell lymphoma
Item
t-cell lymphoma.
boolean
C0079772 (UMLS CUI [1])
CNS or meningeal lymphoma
Item
central nervous system or meningeal involvement by lymphoma.
boolean
C0280803 (UMLS CUI [1])
C2213017 (UMLS CUI [2])
Contraindication to chemotherapy
Item
any contra-indication to any drug contained in the chemotherapy regimens.
boolean
C1301624 (UMLS CUI [1,1])
C0392920 (UMLS CUI [1,2])
Renal and hepatic functio
Item
poor renal function (creatinin level>150µmol/l), poor hepatic function (total bilirubin level>30mmol/l, transaminases>2.5 maximum normal level) unless these abnormalities are related to the lymphoma.
boolean
C0201976 (UMLS CUI [1])
C0201913 (UMLS CUI [2])
C0919834 (UMLS CUI [3])
Comorbidity
Item
serious active disease (according to the investigator’s decision).
boolean
C0009488 (UMLS CUI [1])
Bone marrow function
Item
poor bone marrow reserve as defined by neutrophils <1.5g/l or platelets<100g/l, unless related to bone marrow infiltration.
boolean
C0200633 (UMLS CUI [1])
C0032181 (UMLS CUI [2])
Further malignancies
Item
any history of cancer during the last 5 years with the exception of non-melanoma skin tumors or stage 0 (in situ) cervical carcinoma.
boolean
C0006826 (UMLS CUI [1,1])
C0332196 (UMLS CUI [1,2])
C0007114 (UMLS CUI [1,3])
C0006826 (UMLS CUI [2,1])
C0332196 (UMLS CUI [2,2])
C2216722 (UMLS CUI [2,3])
Experimental drug
Item
treatment with any investigational drug within 30 days before planned first cycle of chemotherapy and during the study.
boolean
C0304229 (UMLS CUI [1])
Pregnancy
Item
childbearing woman.
boolean
C0032961 (UMLS CUI [1])
Organ transplantation
Item
patients previously treated with an organ transplantation.
boolean
C0029216 (UMLS CUI [1])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial